NERVGEN PHARMA CORP. Equity
NERVGEN PHARMA CORP. (NGEN) had Equity of CAD 3.48 million as of 2025-12-31, per its 40-F filed 2026-03-31.
Financial Statements › Notes
ifrs-full:Equity · last filed 2026-03-31
- 2025-12-31: Equity 3.48M CAD.
- 2024-12-31: Equity 2.58M CAD.
- 2023-12-31: Equity -2.01M CAD.
| Period end | Equity |
|---|---|
| 2025-12-31 | 3.48M CAD 40-F · filed 2026-03-31 |
| 2024-12-31 | 2.58M CAD 40-F · filed 2026-03-31 |
| 2023-12-31 | -2.01M CAD 40-F · filed 2026-03-31 |